A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV Drugs
Status:
Completed
Trial end date:
1991-11-01
Target enrollment:
Participant gender:
Summary
To make stavudine (d4T) available to patients with advanced HIV disease for whom no
alternative antiretroviral is satisfactory. To study the safety and efficacy of two dose
levels in a twice-daily regimen.